Autism Spectrum Disorder Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 16 and 25 years old
- People who are biologically male or female
- People who have a formal diagnosis of autism, as defined by the DSM-IV or DSM-5 (including the text revision)
- For people aged 18 and over, a signed personal consent form is required before any screening takes place; for people under 18, a signed consent form from a parent or legal guardian is required, along with the young person's own agreement to take part
Who may not be able to join:
- People who have a history of congenital (present from birth) heart conditions, diagnosed heart or cardiovascular problems, or other physical health conditions that could affect heart rate variability measurements or make breathing exercises unsafe — for example, uncontrolled epilepsy or severe breathing difficulties
- People currently experiencing acute agitation, severe psychiatric symptoms such as psychosis, mania, or major depression, or active substance use
- People with an intellectual disability, defined as an IQ below 70 according to the DSM-IV or DSM-5
- People who do not have sufficient knowledge of the Dutch language to follow instructions and complete questionnaires
- People who are currently pregnant
- People already taking part in another interventional research study, whether or not it involves a medicine or medical device being tested
- People currently taking medication known to affect how the heart is regulated by the nervous system (hormonal contraceptives are not included in this restriction)
- People with a hearing or vision impairment that cannot be corrected to normal functioning with aids such as glasses or hearing devices
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Tine Van Damme, Prof. dr., KU Leuven
Phone: +32 479976950
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in cardiac vagal modulation of heart rate based on resting-state HRV.; Change in cardiac vagal modulation of heart rate based on resting-state HRV
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.